文献速递心血管CT

冠状动脉CT血管成像衍生的左心室长轴缩短率作为经导管主动脉瓣置换术后心室功能障碍早期标志物的可行性

Feasibility of Coronary CT Angiography-derived Left Ventricular Long-Axis Shortening as an Early Marker of Ventricular Dysfunction in Transcatheter Aortic Valve Replacement.
PubMed 文献 · Radiol Cardiothorac Imaging · 2022-06-30

本回顾性研究纳入175例因重度主动脉瓣狭窄行TAVR术前计划性CCTA的患者,测量左心室长轴缩短率(LV-LAS)并随访24个月全因死亡率。LV-LAS可独立预测死亡(校正HR 2.83,95%CI 1.13-7.07,P=0.03),在STS-PROM模型中加入LV-LAS后C指数从0.64升至0.71(P=0.001),在LVEF正常亚组中仍有意义(校正HR 3.98,95%CI 1.56-10.17,P=0.004)。

要点

  • LV-LAS可从TAVR术前CCTA的收缩末期与舒张末期图像测量,用于独立预测术后24个月全因死亡。
  • 在STS-PROM基础上加入LV-LAS可将预测死亡C指数从0.64提升至0.71。
  • LVEF正常的重度AS患者中LV-LAS仍与死亡相关(校正HR 3.98,95%CI 1.56-10.17)。

核心结论

  • LV-LAS可独立预测TAVR患者的死亡,包括LVEF正常者。

研究设计与样本

  • 回顾性研究纳入2014年9月至2019年12月因重度AS行TAVR术前计划CCTA的175例患者(中位年龄79岁,IQR 73-85岁;92例男性),CCTA覆盖整个心动周期以10%增量重建,于收缩末期和舒张末期图像测量LV-LAS,记录TAVR术后24个月内全因死亡。

诊断标准与关键数值

  • LV-LAS预测死亡的校正HR为2.83(95%CI 1.13-7.07,P=0.03);在STS-PROM模型中校正HR为3.38(95CI 1.48-7.72,P=0.004),C指数从0.64升至0.71(χ2=29.9 vs 19.7,P=0.001)。

临床应用与阅片要点

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To evaluate the value of using left ventricular (LV) long-axis shortening (LAS) derived from coronary CT angiography (CCTA) to predict mortality in patients with severe aortic stenosis (AS) undergoing transcatheter aortic valve replacement (TAVR).

MATERIALS AND METHODS: Patients with severe AS who underwent CCTA for preprocedural TAVR planning between September 2014 and December 2019 were included in this retrospective study. CCTA covered the whole cardiac cycle in 10% increments. Image series reconstructed at end systole and end diastole were used to measure LV-LAS. All-cause mortality within 24 months of follow-up after TAVR was recorded. Cox regression analysis was performed, and hazard ratios (HRs) are presented with 95% CIs. The C index was used to evaluate model performance, and the likelihood ratio χ2 test was performed to compare nested models.

RESULTS: The study included 175 patients (median age, 79 years [IQR, 73-85 years]; 92 men). The mortality rate was 22% (38 of 175). When adjusting for predictive clinical confounders, it was found that LV-LAS could be used independently to predict mortality (adjusted HR, 2.83 [95% CI: 1.13, 7.07]; P = .03). In another model using the Society of Thoracic Surgeons Predicted Risk of Mortality (STS-PROM), LV-LAS remained significant (adjusted HR, 3.38 [95 CI: 1.48, 7.72]; P = .004), and its use improved the predictive value of the STS-PROM, increasing the STS-PROM C index from 0.64 to 0.71 (χ2 = 29.9 vs 19.7, P = .001). In a subanalysis of patients with a normal LV ejection fraction (LVEF), the significance of LV-LAS persisted (adjusted HR, 3.98 [95 CI: 1.56, 10.17]; P = .004).

CONCLUSION: LV-LAS can be used independently to predict mortality in patients undergoing TAVR, including those with a normal LVEF.Keywords: CT Angiography, Transcatheter Aortic Valve Implantation/Replacement (TAVI/TAVR), Cardiac, Outcomes Analysis, Cardiomyopathies, Left Ventricle, Aortic Valve Supplemental material is available for this article. © RSNA, 2022See also the commentary by Everett and Leipsic in this issue.

来源:Radiol Cardiothorac Imaging,查看原文。版权归原作者所有。

引用

  1. Aquino, Decker, Schoepf, et al. Feasibility of Coronary CT Angiography-derived Left Ventricular Long-Axis Shortening as an Early Marker of Ventricular Dysfunction in Transcatheter Aortic Valve Replacement. Radiol Cardiothorac Imaging. 2022. PMID: 35833168. doi:10.1148/ryct.210205

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。